Home › Studies › PRJNA1425773
PRJNA1425773 SRP678807

Carotenoid-inulin fermentation, IBS/overweight microbiota

CAROTENOIDS MODULATE EX VIVO FERMENTATION OF INULIN USING IBS AND OVERWEIGHT ADULT GUT MICROBIOTA

407 samples from an ex vivo fermentation study (Ghent, Belgium) using fecal microbiota from IBS and overweight adult donors, testing carotenoids combined with the prebiotic inulin; intervention design. machine-written summary

407 samples · 407 runs · BE · Adult · 2026 · 0.55 Gbp / sample

Sources
✓Sequence archive 2,442✓Abstract / description 407✓Full text 814○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive2,442 sample values (collection date, country, latitude, location locality, location region, longitude)
✓ Abstract / description407 sample values (health condition detail)
✓ Full text814 sample values (antibiotic exposure, smoking status) · PMC13479947
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet · share metadata
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention — arms not resolved

Non-microbial dietary supplement (vitamins Prebiotic / dietary fibre supplement design single_arm_before_after · population ibs · Carotenoids (beta-carotene, lutein, lycopene, zeaxanthin) +/- inulin, ex vivo fermentation

“carotenoids tested alone or together with the prebiotic inulin” — bioproject.description (study level; per-sample arms are in the intervention column below)

Samples at a glance
1 sampling locations · 1 country
Age
adult407
Country
BE407
Body site
primary407
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)this project, 0.1–0.3 Gbp: 65 samplesall projects, 0.3–1 Gbp: 47,044 samples (8 %)this project, 0.3–1 Gbp: 254 samplesall projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 85 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 3 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 0.55 Gbp per sample0130Gbp
Community composition
Faecalibacterium 11.9%Bacteroides 8.2%Collinsella 6.1%Bifidobacterium 5.9%Gemmiger 4.2%Blautia_A 3.3%Alistipes 3.1%Eggerthella 2.9%Mediterraneibacter 2.1%Ruminococcoides 2.1%Escherichia 1.9%Akkermansia 1.8%not assigned to a genus 17.9%other genera 28.6%

Genera, mean relative abundance over 405 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category407 100%
country407 100%407
health_condition0 0%
subject_id0 0%
antibiotic_exposure407 100%407
collection_date407 100%407
detailed_location407 100%
health_condition_detail407 100%407
latitude407 100%407
location_locality407 100%407
location_region407 100%407
longitude407 100%407
smoking_status407 100%407
Papers (1)
  • Carotenoids modulate fermentation of inulin ex vivo in IBS and overweight adult gut microbiota. 2026 PMID 42271199 PMC13479947 own_data
Details
Archive description

Carotenoids have direct antioxidant and anti-inflammatory benefits. Because of their low bioavailability, a portion of carotenoids also reaches the colon, but their interactions with the gut microbiome remain poorly understood.</p><p>Methods: We investigated how beta-carotene (BC), lutein (LU), lycopene (LY), and zeaxanthin (ZE), at biologically relevant doses (1 to 60 mg per day), affect the composition and metabolite production of adult gut microbiota from individuals with irritable bowel syndrome (IBS) and overweight (OW). Experiments were performed using the ex vivo SIFR fermentation system (Systemic Intestinal Fermentation Research). Fresh fecal samples were collected from 12 donors (n = 6 per cohort) and incubated under anaerobic conditions for 24 hours, with carotenoids tested alone or together with the prebiotic inulin (IN, at 2.5 g per day).</p><p>Results: Each cohort showed distinct microbiota profiles at baseline. Carotenoids alone caused only minor changes, but when combined with inulin they significantly altered microbial community composition (Bray-Curtis dissimilarity, P < 0.05) and increased short-chain fatty acid (SCFA) production. Most carotenoids increased butyrate levels compared with inulin alone. ZE at 2 mg per day in IBS (+7.6 percent) and LU at 60 mg per day in OW (+8.0 percent) produced the strongest butyrate increases (P adjusted < 0.10). In contrast, LY at 45 mg per day increased acetate (+3.5 percent) and propionate (+8.0 percent) while reducing butyrate (-7.5 percent, P adjusted < 0.10). SCFA changes were linked to carotenoid- and cohort-specific shifts in the abundance of Bifidobacterium, Alistipes, Akkermansia, Faecalibacterium, and Coprococcus. ZE enhanced the inulin-induced increase of the health-related metabolites 3-phenyllactic acid (PLA) and 2-hydroxyisocaproic acid (HICA), especially in IBS subjects (P adjusted < 0.20).</p><p>Conclusions: Antioxidant carotenoids may support anaerobic gut microbes, including key butyrate producers, and may help counteract phenotype-specific dysbiosis in IBS and overweight individuals. As these benefits occurred when carotenoids were combined with inulin, carotenoids may have stronger effects when consumed with fiber-rich diets, reflecting their natural presence in plant-based foods.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult by deterministic_prior with confidence 0.90. Assay shotgun_dna.

  • host external_curation.infant_catalog · “infant triage reason_code age_adult_only”
  • body site study.title · “AND OVERWEIGHT ADULT GUT MICROBIOTA”
  • body site study.description · “also reaches the colon , but their”
  • life stage external_curation.infant_catalog · “infant triage reason_code age_adult_only”
  • life stage study.title · “IBS AND OVERWEIGHT ADULT GUT MICROBIOTA”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN55871243antibiotic_exposurenoR30.70paper.fulltext.methods_resultsno antibiotic/probiotic intake in 3 months prior to study
SAMN55871243collection_date2022R10.90biosample.attribute:collection_date2022
SAMN55871243countryBER10.90sample.attr.geo_loc_nameBelgium: Ghent
SAMN55871243health_condition_detailmixed_case_control: Two disease groups sampled: IBS (n=6) and overweight (n=6); no healthy controls mentionedR40.50study.titleIBS AND OVERWEIGHT ADULT GUT MICROBIOTA
SAMN55871243latitude51.0543R10.90biosample.attribute:lat_lon51.0543 N 3.7174 E
SAMN55871243location_localityGhentR10.85biosample.attribute:geo_loc_nameBelgium: Ghent
SAMN55871243location_regionFlandersR10.60biosample.attribute:lat_lon51.0543 N 3.7174 E
SAMN55871243longitude3.7174R10.90biosample.attribute:lat_lon51.0543 N 3.7174 E
SAMN55871243smoking_statusneverR30.70paper.fulltext.methods_resultsnon-smoking
Sequencing

407 runs over 407 samples · mean 0.74 Gbp per run (median 0.55 Gbp, total 302.58 Gbp; 407 runs with a base count) · layout PAIRED 406, SINGLE 1 · platform ILLUMINA 407 · models Illumina NovaSeq 6000 (407) · 100% of runs with a Sandpiper profile · first public 2026-03-04

Authors (0)

No author record.

Help complete this project

2 of the 4 core fields are below 50% coverage: health_condition, subject_id. Share metadata

Downloads

PRJNA1425773.csv.gz (10.0 KB) · parquet (84.9 KB) — all 407 samples, every field with route and confidence · PRJNA1425773_determinations.csv.gz (20.5 KB) — 3,663 evidence rows

Samples (407 · every field this project has values for · hover a cell for its source)
Loading the sample table…